Role of leptin in the progression of psoriatic,rheumatoid and osteoarthritis |
| |
Authors: | Jessica Mounessa Iryna Voloshyna Amy D Glass Allison B Reiss |
| |
Affiliation: | Jessica Mounessa, Iryna Voloshyna, Amy D Glass, Allison B Reiss, Winthrop Research Institute and Department of Medicine, Winthrop-University Hospital, SUNY Stony Brook School of Medicine, Mineola, NY 11501, United States |
| |
Abstract: | Leptin, an adipokine responsible for body weight regulation, may be involved in pathological processes related to inflammation in joint disorders including rheumatoid arthritis (RA), osteoarthritis, and psoriatic arthritis (PsA). These arthropathies have been associated with a wide range of systemic and inflammatory conditions including cardiovascular disease, obesity, and metabolic syndrome. As a potent mediator of immune responses, leptin has been found in some studies to play a role in these disorders. Furthermore, current potent biologic treatments effectively used in PsA including ustekinumab (an interleukin 12/23 blocker) and adalimumab (a tumor necrosis factor-alpha blocker also used in RA) have been found to increase leptin receptor expression in human macrophages. This literature review aims to further investigate the role leptin may play in the disease activity of these arthropathies. |
| |
Keywords: | Psoriatic arthritis Rheumatoid arthritis Leptin Ustekinumab Tumor necrosis factor-alpha |
|
| 点击此处可从《World Journal of Rheumatology》浏览原始摘要信息 |
|